Whole saliva and plasma levels of clozapine and desmethylclozapine

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 35-40

  Dumortier, G ^a,c   Lochu, A ^b   Zerrouk, A ^a   Van Nieuwenhuyse, V ^a   Colen De Melo, P ^b   Roche Rabreau, D ^b   Degrassat, K ^a  

^a EPS Ville Evrard   (France)

^b Centre hospitalier de Lagny Marne la Vallee   (France)

^c EPS de Ville Evrard   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DRUG METABOLITE; HALOPERIDOL; NORCLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG SALIVA LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SALIVA; SCHIZOPHRENIA;

EID: 0031872679     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00132.x     Document Type: Article

References (23)

1. Baldessarini RJ, Frankenburg, FR. (1991) Clozapine: A novel antipsychotic agent. New England Journal of Medicine 324, 746-754.
2. Nightingale SL. (1990) Approval of clozapine for refractory schizophrenia. Journal of the American Medical Association 263, 202.
3. Small JG, Milstein, V, Marhenke JD, Hall DD, Kellams JJ. (1987) Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity and treatment resistant psychosis. Journal of Clinical Psychiatry 48, 263-267.
4. Lovdhal MJ, Perry, PJ, Miller DD. (1991) The assay of clozapine and N-Desmethyl-clozapine in human plasma by high-performance liquid chromatography. Therapeutic Drug Monitoring 13, 69-72.
5. Oleson O, Poulsen, B. (1993) One-line fully automated determination of clozapine and desmethylclozapine in human serum by solid-phase extraction on exchangeable cartridges and liquid chromatography using a methanol buffer mobile phase on unmodified silica. Journal of Chromatography 622, 39-46.
6. Perry PJ, Miller, DD, Arndt SV, Cadoret RJ. (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry 148, 231-235.
7. Potkin SG, Bera, R, Gulasekaram B. (1994) Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Journal of Clinical Psychiatry 55 (Suppl. B), 133-136.
8. Stevens I, Gaertner, HJ. (1995) Clozapine plasma level measurements: Kinetic drug interactions with other psychoactive drugs. Campaign on schizophrenia 1995, Critical issues in the treatment of schizophrenia, International Academy for Biomedical and Drug Research, Florence, Italy, 10-12 March, 132. Karger AG, Basel, Switzerland.
9. Hiemke C, Weigmann, H, Härtter S, Dahmen N, Wetzel H, Müller H. (1994) Elevated levels of clozapine in serum after addition of fluvoxamine. Journal of Clinical Psychopharmacology, 14 (4), 279-281.
10. Koponen H, Leinonen, E, Lepola U. (1995) Fluvoxamine increases the clozapine serum levels significantly. Compaign on schizophrenia 1995, Critical issues in the treatment of schizophrenia, International Academy for Biomedical and Drug Research, Florence, Italy, 10-12 March, 130. Karger AG, Basel, Switzerland.
11. Weigmann H, Müller, H, Dahmen N, Wetzel H, Hiemke C. (1993) Interactions of fluvoxamine with the metabolism of clozapine. Pharmacopsychiatry 26, 209.
12. Szegedi A, Wiesner, J, Hiemke C. (1995) Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine. Journal of Clinical Psychopharmacology 5, 141-143.
13. Dumortier G, Lochu A, Colen de Melo P, et al. (1996) Elevated clozapine plasma concentrations after fluvoxamine initiation. American Journal of Psychiatry 153, 738-739.
14. Jerling M, Linsdström, L, Bondesson U, Bertilsson L. (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: Evidence from a therapeutic monitoring service. Therapeutic Drug Monitoring 16, 368-374.
15. Raitasuo V, Lehtovaara, R, Huttunen MO. (1993) Carbamazepine and plasma levels of clozapine. American Journal of Psychiatry 150, 169.
16. Szymanski S, Lieberman, JA, Picou D, Masiar S, Cooper T. (1991) A case report of cimetidine-induced clozapine toxicity. Journal of Clinical Psychiatry 52, 21-22.
17. Miller DD. (1991) Effect of phenytoin on clozapine concentrations in two patients. Journal of Clinical Psychiatry 52, 23-25.
18. Funderburg L, Vertrees, J, True J, Miller A. (1994) Seizure following addition of erythromycin to clozapine treatment. American Journal of Psychiatry 151, 1840-1841.
19. Costello L, Suppes, T. (1995) A clinically significant interaction between clozapine and valproate. Journal of Clinical Psychopharmacology 15, 139-141.
20. Finley P, Warner, D. (1994) Potential impact of valproic acid therapy on clozapine disposition. Biological Psychiatry 36, 487-488.
21. May PR, Van Putten T, Jenden MD, Coradee Y, Dixson WJ. (1981) Chlorpromazine levels and the outcome of treatment in schizophrenic patients. Archives of General Psychiatry 38, 202-207.
22. Yamazumi S, Miura, S. (1981) Haloperidol concentrations in saliva and serum: Determination by radioimmunoassay method. International Pharmacopsychiatry 16, 174-183.
23. Zohar J, Birmaher, B, Schoenfeld H, Belmaker R. (1986) Salivary and blood levels of neuroleptics during outpatient maintenance treatment. Israel Journal of Psychiatry Related Sciences 23, 123-128.